{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZLDPF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZLDPF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLDPF\",,,,,undefined,":{"symbol":"ZLDPF","market":"US","secType":"STK","nameCN":"Zealand Pharma A/S","latestPrice":67.624,"timestamp":1748462400000,"preClose":69.32,"halted":0,"volume":252,"delay":15,"floatShares":60575983,"shares":70935412,"eps":-1.807241,"marketStatus":"Closed","change":-1.696,"latestTime":"05-28 16:00:00 EDT Delay","open":69,"high":69,"low":67.624,"amount":17252.699999999997,"amplitude":0.01985,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.807241,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748505600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":69.32,"volumeRatio":1.042184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLDPF\",,,,,undefined,":{"symbol":"ZLDPF","floatShares":60575983,"roa":"-13.97%","roe":"-21.27%","lyrEps":-1.844231,"volumeRatio":1.042184,"shares":70935412,"dividePrice":0,"high":69,"amplitude":0.01985,"preClose":69.32,"low":67.624,"week52Low":57.97,"pbRate":"3.92","psRate":"585.23","week52High":141.742,"institutionHeld":0,"latestPrice":67.624,"eps":-1.807241,"divideRate":0,"volume":252,"delay":15,"ttmEps":-1.807241,"open":69,"prevYearClose":102.36,"prevWeekClose":62.3556,"prevMonthClose":72.28,"prevQuarterClose":75.6,"fiveDayClose":63.42,"twentyDayClose":66.94,"sixtyDayClose":83.902},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ZLDPF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZLDPF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536682068","title":"Zealand Pharma appoints Johnson as Chief Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2536682068","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536682068?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:10","pubTimestamp":1747660245,"startTime":"0","endTime":"0","summary":"Zealand Pharma (ZLDPF) announces the appointment of Steven Johnson as Chief Development Officer. Steven will join the executive team to lead regula...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zealand-pharma-appoints-johnson-as-chief-development-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zealand-pharma-appoints-johnson-as-chief-development-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZLDPF"],"gpt_icon":0},{"id":"2532004577","title":"Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2532004577","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532004577?lang=en_us&edition=fundamental","pubTime":"2025-05-01 23:05","pubTimestamp":1746111900,"startTime":"0","endTime":"0","summary":"Copenhagen, Denmark,May 1, 2025–Zealand Pharma A/S  , a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on May 8, 2025, at 2:00 pm CET  following the announcement of financial results for the first quarter / first three months of 2025.Participating in the call will be President and Chief Executive Officer, Adam Steensberg; Chief Financial Officer, Henriette Wennicke; Chief Medical Officer, David Kendall; and Chief Commercial Officer, Eric Cox. The presentation will be followed by a Q&A session.Zealand Pharma A/S  is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial pa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zealand-pharma-conference-call-may-150500602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","ET","BK4581","BK4139","BK4590","BK4561","ZLDPF","BK4588","BK4144"],"gpt_icon":0},{"id":"2532887022","title":"Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532887022","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532887022?lang=en_us&edition=fundamental","pubTime":"2025-05-01 16:23","pubTimestamp":1746087780,"startTime":"0","endTime":"0","summary":"Zealand Pharma A/S  shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.3% loss over the past four weeks.Last month, the company announced that it has enrolled the first participant in the phase IIb ZUPREME-2 study. This study evaluates the efficacy and safety of petrelintide versus placebo in people with obesity and type 2 diabetes. Enrollment in the ZUPREME-2 study is expected to be completed in the second half of 2025. The growing optimism related to the development of petrelintide might have driven the recent share price rally.Zealand Pharma AS belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Akoya Biosciences , closed the last trading session 5.5% lower at $1.20. Over the past month, AKYA has returned -5.9%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zealand-pharma-zldpf-stock-jumps-082300223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZLDPF","AKYA","BK4539","BK4139","BK4121"],"gpt_icon":0},{"id":"2529446683","title":"Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2529446683","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529446683?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:00","pubTimestamp":1745413200,"startTime":"0","endTime":"0","summary":"Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity and related complications. He will lead the discovery and clinical translation of peptide medicines, investing in new technologies including data and computational science. Utpal to expand the global scientific team to drive Zealand Pharma’s next wave of highly differentiated, innovative therapies, building on the Company’s strong drug development heritage. Copenhagen, Denmark, 23 April 2025 –Zealand Pharma A/S  , a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the appointment of Utpal Singh as Chief Scientific Officer. Utpal will join the executive team to lead discovery research and translational sciences at Zealand Pharma.Zealand Pharma A/S   is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zealand-pharma-appoints-utpal-singh-130000184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ZLDPF"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZLDPF\",params:#limit:5,,,undefined,":[{"date":"2024-05-16","symbol":"ZLDPF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715846400000,"name":null,"time":"Pre-Market","dateTimestamp":1715832000000,"actualEps":null},{"market":"US","date":"2022-11-10","symbol":"ZLDPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1668056400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZLDPF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZLDPF\",market:\"US\",delay:false,,,undefined,":{}}}